OAC
CRBU icon

OMERS Administration Corp’s Caribou Biosciences CRBU Stock Holding History

OMERS Administration Corp’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$228K Sell
120,200
-57,900
-33% -$99.4K ﹤0.01% 890
2025
Q4 		$283K Buy
+178,100
New +$374K ﹤0.01% 826

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OMERS Administration Corp's CRBU Position: Q1 2026 in Review

OMERS Administration Corp reduced its Caribou Biosciences (CRBU) stake by 33% in Q1 2026, selling an estimated $99.4K and leaving 120,200 shares worth $228K. The position accounts for ﹤0.01% of the portfolio, ranked #890.

OMERS Administration Corp first reported a position in CRBU in Q4 2025 and has held it in 2 quarters since. The position peaked at $283K in Q4 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • OMERS Administration Corp held 120,200 shares of Caribou Biosciences worth $228K as of Q1 2026.
  • OMERS Administration Corp sold 57,900 Caribou Biosciences shares in Q1 2026, an estimated $99.4K.
  • Caribou Biosciences made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #890 holding.
  • OMERS Administration Corp first reported a position in Caribou Biosciences in Q4 2025 and has held it in 2 quarters since.
  • OMERS Administration Corp's Caribou Biosciences position peaked at $283K in Q4 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.